Stocks and InvestingStocks and Investing
Tue, June 18, 2024
Mon, June 17, 2024
Fri, June 14, 2024
Thu, June 13, 2024

Hartaj Singh Maintained (SPRB) at Buy with Decreased Target to $3 on, Jun 13th, 2024


Published on 2024-10-28 11:55:02 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $4 to $3 on, Jun 13th, 2024.

Hartaj has made no other calls on SPRB in the last 4 months.



There are 6 other peers that have a rating on SPRB. Out of the 6 peers that are also analyzing SPRB, 5 agree with Hartaj's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Hold on, Wednesday, June 5th, 2024
  • Aydin Huseynov of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
  • Evan Wang of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, March 14th, 2024
  • Gregory Renza of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024
  • Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 14th, 2024


This is the rating of the analyst that currently disagrees with Hartaj


  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $3 on, Thursday, March 14th, 2024